Effects of FGF21‐secreting adipose‐derived stem cells in thioacetamide‐induced hepatic fibrosis

Mesenchymal stem cells (MSCs) have been investigated to treat liver diseases, but the efficiency of MSCs to treat chronic liver diseases is conflicting. FGF21 can reduce inflammation and fibrosis. We established FGF21‐secreting adipose derived stem cells (FGF21_ADSCs) to enhance the effects of ADSCs...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Hwansu, Seo, Eunhui, Park, Jong‐Moon, Han, Na‐Young, Lee, Hookeun, Jun, Hee‐Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156392/
https://www.ncbi.nlm.nih.gov/pubmed/30019838
http://dx.doi.org/10.1111/jcmm.13795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156392/
https://www.ncbi.nlm.nih.gov/pubmed/30019838
http://dx.doi.org/10.1111/jcmm.13795

Ejemplares similares